MWM
GILD icon

Meridian Wealth Management’s Gilead Sciences GILD Stock Holding History

Meridian Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.17M Sell
40,890
-825
-2% -$109K 0.16% 128
2026
Q1 		$5.81M Sell
41,715
-148
-0.4% -$20.7K 0.2% 100
2025
Q4 		$5.14M Sell
41,863
-6
-0% -$729 0.18% 106
2025
Q3 		$4.65M Sell
41,869
-897
-2% -$102K 0.18% 107
2025
Q2 		$4.74M Buy
42,766
+1,140
+3% +$121K 0.2% 106
2025
Q1 		$4.66M Sell
41,626
-1,849
-4% -$191K 0.23% 97
2024
Q4 		$4.02M Buy
43,475
+1,026
+2% +$92.4K 0.19% 115
2024
Q3 		$3.56M Buy
+42,449
New +$3.24M 0.17% 126
2024
Q2 		– Sell
-42,121
Closed -$3.09M – 380
2024
Q1 		$3.09M Buy
42,121
+1,314
+3% +$101K 0.51% 38
2023
Q4 		$3.31M Buy
40,807
+17,761
+77% +$1.38M 0.21% 109
2023
Q3 		$1.73M Buy
23,046
+11,293
+96% +$869K 0.11% 171
2023
Q2 		$906K Buy
11,753
+242
+2% +$19.3K 0.08% 219
2023
Q1 		$955K Buy
11,511
+736
+7% +$61K 0.08% 212
2022
Q4 		$925K Sell
10,775
-13,069
-55% -$1.03M 0.09% 205
2022
Q3 		$1.47M Sell
23,844
-18,833
-44% -$1.19M 0.16% 136
2022
Q2 		$2.64M Sell
42,677
-429
-1% -$26.6K 0.22% 117
2022
Q1 		$2.56M Buy
43,106
+3,945
+10% +$252K 0.28% 83
2021
Q4 		$2.84M Buy
39,161
+4,138
+12% +$285K 0.3% 76
2021
Q3 		$2.45M Buy
35,023
+3,728
+12% +$262K 0.3% 72
2021
Q2 		$2.15M Buy
31,295
+6,323
+25% +$422K 0.27% 78
2021
Q1 		$1.61M Buy
24,972
+4,119
+20% +$266K 0.23% 85
2020
Q4 		$1.21M Sell
20,853
-1,335
-6% -$80.6K 0.19% 99
2020
Q3 		$1.4M Buy
22,188
+1,287
+6% +$89.2K 0.34% 64
2020
Q2 		$1.61M Buy
20,901
+10,120
+94% +$776K 0.54% 39
2020
Q1 		$805K Buy
+10,781
New +$745K 0.36% 59
2019
Q1 		– Sell
-7,342
Closed -$459K – 204
2018
Q4 		$459K Buy
+7,342
New +$513K 0.27% 74
2017
Q1 		– Sell
-3,022
Closed -$216K – 168
2016
Q4 		$216K Buy
+3,022
New +$225K 0.17% 119

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Meridian Wealth Management's GILD Position: Q2 2026 in Review

Meridian Wealth Management reduced its Gilead Sciences (GILD) stake by 2% in Q2 2026, selling an estimated $109K and leaving 40,890 shares worth $5.17M. The position accounts for 0.16% of the portfolio, ranked #128.

Meridian Wealth Management first reported a position in GILD in Q4 2016 and has held it in 27 quarters since. The position peaked at $5.81M in Q1 2026. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Meridian Wealth Management held 40,890 shares of Gilead Sciences worth $5.17M as of Q2 2026.
  • Meridian Wealth Management sold 825 Gilead Sciences shares in Q2 2026, an estimated $109K.
  • Gilead Sciences made up 0.16% of Meridian Wealth Management's portfolio in Q2 2026, its #128 holding.
  • Meridian Wealth Management first reported a position in Gilead Sciences in Q4 2016 and has held it in 27 quarters since.
  • Meridian Wealth Management's Gilead Sciences position peaked at $5.81M in Q1 2026.
  • 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Meridian Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.